| Literature DB >> 30040158 |
Maria Saveria Gilardini Montani1, Roberta Santarelli1, Luca Falcinelli1, Roberta Gonnella1, Marisa Granato1, Livia Di Renzo1, Laura Cuomo2, Marina Vitillo2, Alberto Faggioni1, Mara Cirone1.
Abstract
Programmed death ligand 1 (PD-L1) (also called B7-H1) is a membrane immune-modulatory protein whose overexpression on the surface of tumor cells as well as APCs impairs T-cell-mediated killing. Viruses that establish chronic infections have developed a number of strategies to escape from immune recognition including the up-regulation of PD-L1. This study shows for the first time that the human oncovirus EBV infects human primary monocytes using HLA-DR and induced a strong up-regulation of PD-L1 expression on their surface. Searching for the underlying mechanism/s leading to this immune suppressive effect, we found that EBV activated TLR signaling, increased intracellular ROS, and phosphorylated STAT3. Targeting these molecules partially reverted PD-L1 up-regulation that correlated with an altered cytokine production and a reduction of monocyte cell survival, strongly impairing the antiviral immune response. ©2018 Society for Leukocyte Biology.Entities:
Keywords: EBV; MAPK; PD-L1; STAT3; TLR; monocytes
Mesh:
Substances:
Year: 2018 PMID: 30040158 DOI: 10.1002/JLB.2A0118-029RR
Source DB: PubMed Journal: J Leukoc Biol ISSN: 0741-5400 Impact factor: 4.962